As of 6 Nov 2026, Kobo Biotech is loss-making on a trailing 12-month basis, with a net loss of ₹5.23 Cr, so it has no P/E ratio. The share price is ₹3.63, 64% below its 52-week high. Its net worth is negative, as liabilities exceed assets, and borrowings are ₹140 Cr. It is a small-cap company with a market cap of ₹8.65 Cr, ranked 150th of 154 Drug Manufacturers (Specialty & Generic) companies by market cap; the shares rose 13% over the past year.
- ₹3.72
- ₹3.76
- ₹3.63
- ₹3.69
- 19.8K
Health check
- ReturnsBehind
+12.8% over a year, better than 2 of 7 peers.
- Price tagNegative equity
Book value is below zero, so P/E and P/B mislead here.
- Growthn/a
Not enough yearly results to measure.
- ProfitabilityDistorted
With negative net worth, return ratios are meaningless.
- Balance sheetStretched
Negative net worth: liabilities exceed assets.
- Red flags3 to check
Loss-making over the last twelve months.
Small cap
Defensive
Key metrics
- Market cap
- ₹8.65 Cr
- Small cap
- P/E
- n/a
- Industry 28.7
- Price to book
- −0.06
- Peers 4.99
- Dividend yield
- 0.00%
- ROE
- n/a
- Peers 14.7%
- ROCE
- n/a
- Peers 17.9%
- Debt to equity
- n/a
- Debt ₹140 Cr
- EPS (TTM)
- −₹2.16
- OPM (TTM)
- −6751.6%
- Net margin 0.0%
- Sales growth
- n/a
- Year-ago quarter not reported
- Profit growth
- n/a
- Year-ago quarter not reported
- Price to sales
- 113.80
- EV/EBITDA −138.7
Strengths and risks
Strengths
- Positive operating cash flow in each of the last 4 years.
Risks to check
- Loss-making over the last twelve months.
- Negative net worth: liabilities exceed assets.
- 64% below its 52-week high.
About Kobo Biotech
Kobo Biotech Limited manufactures and sells active pharmaceutical ingredients based on fermentation technology in India. The company was formerly known as Avon Lifesciences Limited and changed its name to Kobo Biotech Limited in October 2020. The company was incorporated in 1993 and is based in Mumbai, India.
- Headquarters
- Mumbai
- Sector
- Healthcare
- ISIN
- INE881A01015
- Website
- kobobiotech.com
Price range
- Avg volume (3M)
- 15.1K
- 1-year return
- plus 12.8%
- From 52-week high
- minus 63.7%
Peers · Drug Manufacturers - Specialty & Generic
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMASun Pharmaceutical Industries | 1,860.00 | plus 1.69% | 4,46,276 | 40.7 | 4.99 | 17.9% | 13.1% | 28.2% | 10.4% | 10.6% | 0.86% | plus 8.2% |
| DIVISLABDivi's Laboratories | 10,320.50 | plus 1.78% | 2,73,977 | 93.6 | 16.35 | 19.0% | 16.2% | 34.9% | 11.0% | 12.1% | 0.29% | plus 49.0% |
| TORNTPHARMTorrent Pharmaceuticals | 4,750.00 | plus 0.85% | 1,80,675 | 80.2 | 9.83 | 9.1% | 15.7% | 33.7% | 13.3% | 20.2% | 0.80% | plus 31.7% |
| LAURUSLABSLaurus Labs | 2,340.00 | minus 0.26% | 1,26,433 | 94.4 | 20.86 | 19.5% | 24.0% | 30.4% | 3.8% | 4.0% | 0.09% | plus 138.6% |
| ZYDUSLIFEZydus Lifesciences | 1,197.90 | plus 0.41% | 1,19,491 | 28.6 | 4.29 | 19.0% | 14.7% | 26.2% | 16.5% | 37.0% | 0.08% | plus 22.8% |
| DRREDDYDr. Reddy's Laboratories | 1,373.00 | plus 0.51% | 1,14,462 | 40.9 | 2.96 | 14.2% | 7.3% | 15.9% | 11.0% | −1.7% | 0.58% | plus 13.8% |
| CIPLACipla | 1,411.00 | plus 0.49% | 1,13,993 | 39.4 | 3.22 | 14.9% | 8.3% | 17.3% | 7.2% | 11.5% | 0.92% | minus 6.6% |
| KOBOKobo Biotech | 3.63 | minus 1.63% | 9 | – | −0.06 | – | – | −6751.6% | – | – | 0.00% | plus 12.8% |
| Median of 7 peers | – | 0.51% | 1,26,433 | 40.9 | 4.99 | 17.9% | 14.7% | 28.2% | 11.0% | 11.5% | 0.58% | 22.8% |
Quarterly results
This company doesn’t report these figures in a format we can read yet.
Profit & loss
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| 121 | −0.9 | −0.8 | −1.1 | |
| −8.9 | −0.5 | −0 | −0.1 | |
| 0.1 | – | – | – | |
| 4.6 | 4.1 | 4.1 | 4.1 | |
| −123 | – | – | – | |
| −15.2 | −5.6 | −4.9 | −5.2 | |
| −15.2 | −5.6 | −4.9 | −5.2 | |
| -6.39 | -2.33 | -2.07 | – |
Forecast
Balance sheet
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| 23.8 | 23.8 | 23.8 | 23.8 | |
| −146 | −152 | −157 | −162 | |
| 141 | 140 | 140 | 140 | |
| 60.9 | 63.5 | 64.6 | 70 | |
| 79.2 | 75.3 | 71.4 | 71.6 | |
| 41.7 | 37.6 | 33.5 | 29.4 | |
| 0.1 | 0.1 | 0.2 | 4.4 | |
| 37.4 | 37.6 | 37.7 | 37.8 | |
| 79.2 | 75.3 | 71.4 | 71.6 |
Cash flow
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| 93.8 | 0.9 | 2.6 | 4.2 | |
| 25.1 | – | 4.1 | – | |
| −120 | −0.9 | −1 | – | |
| −1.4 | 0 | 5.6 | 4.2 | |
| 93.8 | 0.9 | 2.6 | 4.2 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.